EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy-Reference-Cited by-同舟云学术

EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy

Published:2023-12 Issue: Volume:116 Page:103166
ISSN:1120-1797
Container-title:Physica Medica
language:en
Short-container-title:Physica Medica

Author:

Sjögreen-Gleisner Katarina,Flux Glenn^ORCID,Bacher Klaus,Chiesa Carlo^ORCID,de Nijs Robin,Kagadis George C.^ORCID,Lima Thiago,Georgosopoulou Maria Lyra,Gabiña Pablo Minguez,Nekolla Stephan,Peters Steffie^ORCID,Santos Joao,Sattler Bernhard,Stokke Caroline^ORCID,Tran-Gia Johannes^ORCID,Gilligan Paddy^ORCID,Bardiès Manuel^ORCID

Funder

Swedish Cancer Foundation

Swedish Cancer Society

Mrs Berta Kamprad foundation for exploration and combat cancer

Publisher

Elsevier BV

Subject

General Physics and Astronomy,Radiology, Nuclear Medicine and imaging,General Medicine,Biophysics

Reference51 articles.

1. Radionuclide therapy of hematologic disorders;Silberstein;Semin Nucl Med,1979

2. Radiopharmaceutical therapy in cancer: clinical advances and challenges;Sgouros;Nat Rev Drug Discov,2020

3. EFOMP Malaga Declaration 2023: An updated vision on Medical Physics in Europe;Byrne;Phys Med,2023

4. Council Directive 2013/59/Euratom,. Official Journal of the European Union, 20157.

5. Publication 103, Recommendations of the International Commission on Radiological Protection;International Commission on Radiological Protection;Ann ICRP,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of dosimetry for molecular radiotherapy; results from a European survey;Physica Medica;2024-01

2. The contest between internal and external-beam dosimetry: The Zeno’s paradox of Achilles and the tortoise;Physica Medica;2024-01

3. Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence;European Journal of Nuclear Medicine and Molecular Imaging;2023-12-19